Trial Details

COMPLETED
Basic Information
Clinical ID c909
Identifier NCT01453491
Trial Title A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: SRT2104
Participant Information
Sponsor Sirtris, a GSK Company
City Anaheim
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2012-02-13
Primary Completion Date 2013-03-18
Completion Date 2013-03-18